Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 125 for kidney and hypertension

Edit search filters
  1. A Study Of Obinutuzumab To Evaluate The Safety And Tolerability In Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

    Rochester, MN

  2. Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant

    Rochester, MN

  3. A Study to Examine The Effectiveness, Feasibility, and Acceptability of Exercise Intervention on Frailty After Kidney Transplantation.

    Rochester, MN

  4. Acute Kidney Injury in Care Transitions (ACT) Trial

    Rochester, MN

  5. A Study Of RGLS8429 In Patients With Autosomal Dominant Polycystic Kidney Disease

    Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate The Efficacy And Safety Of A Vaccine, ASP0113, In Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving An Organ From A CMV-Seropositive Donor

    Scottsdale/Phoenix, AZ

  7. A Safety, Pharmacokinetic And Dose-Escalation Study Of KD019 In Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Rochester, MN

  8. Clazakizumab For The Treatment Of Chronic Active Antibody Mediated Rejection In Kidney Transplant Recipients (IMAGINE)

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Stem Cell Therapy for Chronic Kidney Disease

    Jacksonville, FL

  10. A Study to Evaluate Patient Outcomes in Care Transition of Acute Kidney Injury (AKI) Survivors

    Rochester, MN

.

Mayo Clinic Footer